Newsletter
Before the first call of the day.
Every morning at 7am ET, we send the day's nine most-important filings, deals, and enforcement actions. Written for people who read the primary sources anyway.
hello@the483.com · Early access · Free · No sponsor copy
№ 113
Nine observations you didn't want to receive this morning.
Stalls Rovirosa FCPA Appeal, Seeks 30 More Days
DOJ filed a notice of appeal in the Rovirosa FCPA acquittal case, then admitted the Solicitor General hasn't decided if it wants one.
Also on the docket
AstraZeneca Pays CSPC $30M for $1.77B Kidney Deal
AstraZeneca puts just $30M down now to control up to $1.77B in kidney-drug milestones, its fourth check written to Chinese partner CSPC since 2024.
MEP Probing Pegasus Abuse Got Hacked With Pegasus
A spyware investigator got spied on by the exact tool he was investigating. It's a live case study in why patch cadence isn't a security strategy.
Payward Buys Reap for $600M in Stablecoin Bet
Kraken's parent paid up to $600M for a Hong Kong payments firm — here's what Payward actually bought, and why the discount to Stripe's Bridge deal.
● What you get
The brief
Nine filings, ranked. FDA letters, SEC orders, deals, docket updates. The dollar figure lives in the first sentence.
● What you won't get
No slop
No sponsored links masquerading as analysis. No market predictions. No "here are five trends to watch." Just the filings.
● Who reads us
People with standing
Compliance officers, GCs, deal lawyers, buy-side analysts. People who already read primary documents and want the context filled in fast.